Orelabrutinib, a Selective Bruton's Tyrosine Kinase (BTK) Inhibitor in the Treatment of Primary Immune Thrombocytopenia (ITP)
Author:
Tianshu Yu,Lingjun Wang,Xiaofei Ni,Yu Hou,Xinguang Liu,Ming Hou
Copyright © 2021 American Society of Hematology. Published by Elsevier Inc. All rights reserved.